Jacob B Schwartz

Title: Jacob B Schwartz: Innovator in Glycoconjugate Research

Introduction

Jacob B Schwartz is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of glycoconjugate research, particularly in the development of novel compounds that have potential applications in cancer treatment. His work is characterized by innovative approaches to synthesis and application of these compounds.

Latest Patents

Jacob B Schwartz holds a patent for &agr;-O-linked glycoconjugates, methods of preparation and uses thereof. This invention provides novel &agr;-O-linked glycoconjugates, including &agr;-O-linked glycopeptides, and outlines convergent methods for their synthesis. The patent exemplifies a general preparative approach, particularly focusing on the synthesis of the mucin motif commonly found on epithelial tumor cell surfaces. Furthermore, the invention offers compositions and methods for treating cancer using these &agr;-O-linked glycoconjugates.

Career Highlights

Jacob B Schwartz is affiliated with the Sloan-Kettering Institute for Cancer Research, where he continues to advance his research in glycoconjugates. His work has garnered attention for its potential impact on cancer therapies, showcasing his commitment to innovative solutions in medical research.

Collaborations

Throughout his career, Jacob has collaborated with notable scientists, including Samuel J Danishefsky and Dalibor Sames. These collaborations have enriched his research and contributed to the advancement of glycoconjugate science.

Conclusion

Jacob B Schwartz is a key figure in the field of glycoconjugate research, with a focus on developing innovative methods for cancer treatment. His contributions through patents and collaborations highlight his dedication to advancing medical science.